Senate Finance Committee Chair Ron Wyden (D-OR) will back FDA chief-nominee Robert Califf when his nomination comes to the Senate floor for a vote, the senator announced Thursday (Feb. 10) after Califf affirmed he would take strong action to make sure sponsors of drugs that make it to market under the accelerated approval pathway are held accountable for quickly gathering postmarket data. Califf said FDA would use “every authority at its disposal” to keep companies accountable under his helm, and...